Search Results - "King, Vickie"

A bivalent porcine circovirus type 2 (PCV2), PCV2a-PCV2b, vaccine offers biologically superior protection compared to monovalent PCV2 vaccines by Bandrick, Meggan, Balasch, Monica, Heinz, Andrea, Taylor, Lucas, King, Vickie, Toepfer, Jeri, Foss, Dennis

“…Recent publications suggest PCV2 vaccine-induced protection is superior when the vaccine and challenge are closely matched. PCV2's evolutionary rate,…”
Get full text

Acceptance of oclacitinib maleate (Apoquel®) chewable tablets in client-owned dogs with allergic and atopic dermatitis by Visser, Marike, Walsh, Kelly, King, Vickie, Sture, Gordon, Caneva, Laura

“…The oral acceptance of oclacitinib maleate (Apoquel®) chewable tablets administered twice daily for 7 days at the labeled dose range of 0.4-0.6 mg/kg was…”
Get full text

Efficacy of three consecutive monthly doses of a topical formulation of selamectin and sarolaner (Revolution® Plus/Stronghold® Plus) compared with a single dose of fluralaner (Bravecto® for Cats) against induced infestations of Ctenocephalides felis on cats by Vatta, Adriano F., King, Vickie L., Young, David R., Chapin, Sara

“…•Efficacy of one dose of fluralaner was compared with three consecutive monthly doses of selamectin/sarolaner.•Based on geometric means, selamectin/sarolaner…”
Get full text

Experimental veterinary SARS-CoV-2 vaccine cross neutralization of the Delta (B.1.617.2) variant virus in cats by Hoyte, Ashley, Webster, Mark, Ameiss, Keith, Conlee, Douglas A., Hainer, Nicole, Hutchinson, Kendra, Burakova, Yulia, Dominowski, Paul J., Baima, Eric T., King, Vickie L., Rosey, Everett L., Hardham, John M., Millership, Jason, Kumar, Mahesh

“…SARS-CoV-2 has exhibited varying pathogenesis in a variety of Mammalia family’s including Canidae, Mustelidae, Hominidae, Cervidae, Hyaenidae, and Felidae…”
Get full text

Efficacy of a new spot-on formulation of selamectin plus sarolaner in the treatment of Otodectes cynotis in cats by Becskei, Csilla, Reinemeyer, Craig, King, Vickie L., Lin, Dan, Myers, Melanie R., Vatta, Adriano F.

“…•Selamectin/sarolaner is effective (≥99.2%) against Otodectes cynotis in cats.•There were no serious adverse reactions to treatment.•Induced infestations with…”
Get full text

Laboratory safety evaluation of lokivetmab, a canine anti-interleukin-31 monoclonal antibody, in dogs by Krautmann, Matthew, Walters, Rodney R., King, Vickie L., Esch, Kevin, Mahabir, Sean P., Gonzales, Andrea, Dominowski, Paul J., Sly, Laurel, Mwangi, Duncan, Foss, Dennis L., Rai, Sharath, Messamore, James E., Gagnon, Genevieve, Schoell, Adam, Dunham, Steven A., Martinon, Olivier M.

“…Lokivetmab (Cytopoint®, Zoetis) is a canine monoclonal antibody that specifically binds and neutralizes interleukin (IL)-31. Lokivetmab is approved for use in…”
Get full text

Efficacy of a new spot-on formulation of selamectin plus sarolaner against four common tick species infesting cats in Europe by Geurden, Thomas, Becskei, Csilla, Vatta, Adriano F., Slootmans, Nathalie, von Reitzenstein, Marcela, King, Vickie L., Lin, Dan, Rugg, Douglas

“…•Treatment of existing infestations is ≥95.9% within 48h.•Persistent efficacy for at least 5 weeks against I. ricinus and I. hexagonus, and for at least 4…”
Get full text

The efficacy of a novel topical formulation of selamectin plus sarolaner (Revolution® Plus/Stronghold® Plus) in preventing the development of Dirofilaria immitis in cats by McTier, Tom L., Pullins, Aleah, Chapin, Sara, Rugg, Jady, von Reitzenstein, Marcela, McCall, John W., King, Vickie L., Vatta, Adriano F.

“…•Cats were inoculated with heartworms 30 days prior to treatment.•Selamectin (6 mg/kg) plus sarolaner (1 mg/kg) was administered topically to cats.•In these…”
Get full text

The speed of kill of a topical combination of selamectin plus sarolaner against induced infestations of Ixodes scapularis ticks on cats by Vatta, Adriano F., Everett, William R., Cherni, Judith A., King, Vickie L., Rugg, Douglas

“…•Speed of kill of selamectin plus sarolaner was evaluated against Ixodes scapularis in cats.•Selamectin plus sarolaner started to kill ticks within 12 h after…”
Get full text

Efficacy and safety of a combination of selamectin plus sarolaner for the treatment and prevention of flea infestations and the treatment of ear mites in cats presented as veterinary patients in the United States by Vatta, Adriano F., Myers, Melanie R., Rugg, Jady J., Chapin, Sara, Pullins, Aleah, King, Vickie L., Rugg, Douglas

“…•Two clinical field studies were conducted in cats in the United States.•Selamectin (6–12 mg/kg) plus sarolaner (1–2 mg/kg) provided >95% control of fleas…”
Get full text

A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs by Little, Peter R., King, Vickie L., Davis, Kylie R., Cosgrove, Sallie B., Stegemann, Michael R.

“…Background Ciclosporin is approved for the treatment of atopic dermatitis (AD) in dogs and has been shown to be safe and effective. Placebo‐controlled studies…”
Get full text

Efficacy and speed of kill of a new spot-on formulation of selamectin plus sarolaner against flea infestations in cats by Becskei, Csilla, Cherni, Judith A., Vatta, Adriano F., King, Vickie L., Lin, Dan, Rugg, Douglas

“…•A single application of selamectin/sarolaner was effective for treatment and month-long control of fleas.•Killing of fleas started within 6 to12h of treatment…”
Get full text

Efficacy of oclacitinib (Apoquel®) compared with prednisolone for the control of pruritus and clinical signs associated with allergic dermatitis in client-owned dogs in Australia by Gadeyne, Caroline, Little, Peter, King, Vickie L., Edwards, Nigel, Davis, Kylie, Stegemann, Michael R.

“…Background Oral glucocorticoids are widely used to reduce pruritus and dermatitis associated with allergic dermatitis. Data suggest that oclacitinib, a Janus…”
Get full text

Comparative efficacy of topical treatments with Revolution® Plus (selamectin and sarolaner) and Bravecto® for Cats (fluralaner) against Ixodes scapularis ticks on cats by Vatta, Adriano F., Young, David R., King, Vickie L., Myers, Melanie R.

“…•Efficacy of three consecutive monthly doses of selamectin/sarolaner was compared with one dose of fluralaner.•Based on geometric means, both…”
Get full text

A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client-owned dogs with atopic dermatitis by Cosgrove, Sallie B., Wren, Jody A., Cleaver, Dawn M., Walsh, Kelly F., Follis, Stacey I., King, Vickie I., Tena, Jezaniah-Kira S., Stegemann, Michael R.

“…Background Pruritus is the hallmark clinical sign of atopic dermatitis (AD) in dogs. Preliminary study results suggest that oclacitinib, a selective Janus…”
Get full text

Efficacy of a new spot-on formulation of selamectin plus sarolaner against Ancylostoma tubaeforme and Toxocara cati in cats by Geurden, Thomas, Vatta, Adriano F., Slootmans, Nathalie, King, Vickie L., Lin, Dan, McTier, Tom, Rugg, Douglas

“…•Selamectin was >94.3% effective against adult but not immature Ancylostoma tubaeforme and Toxocara cati.•Sarolaner did not interfere with the anthelmintic…”
Get full text

Efficacy of a topical formulation of selamectin plus sarolaner against induced infestations of Amblyomma americanum on cats and prevention of Cytauxzoon felis transmission by Reichard, Mason V., Rugg, Jady J., Thomas, Jennifer E., Allen, Kelly E., Barrett, Annie W., Murray, Jill K., Herrin, Brian H., Beam, Rachel A., King, Vickie L., Vatta, Adriano F.

“…•Efficacy of selamectin plus sarolaner was >90% against Amblyomma americanum adults at 72 h post-infestation.•Topical treatment with selamectin plus sarolaner…”
Get full text

Efficacy of a new topical formulation containing selamectin plus sarolaner against three common tick species infesting cats in the United States by Vatta, Adriano F., Young, David R., Everett, William R., King, Vickie L., Cherni, Judith A., von Reitzenstein, Marcela, Holzmer, Susan J., Chapin, Sara, Rugg, Douglas

“…•Efficacy was assessed against three ticks found on cats in the US.•Treatment with selamectin plus sarolaner resulted in >90% control of existing…”
Get full text

Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis by Cosgrove, Sallie B., Wren, Jody A., Cleaver, Dawn M., Martin, David D., Walsh, Kelly F., Harfst, Jessica A., Follis, Stacey L., King, Vickie L., Boucher, Joseph F., Stegemann, Michael R.

“…Background Oclacitinib (Apoquel®) inhibits the function of a variety of pro‐inflammatory, pro‐allergic and pruritogenic cytokines that are dependent on Janus…”
Get full text

VANGUARD®crLyme: A next generation Lyme disease vaccine that prevents B. burgdorferi infection in dogs by Marconi, Richard T., Garcia-Tapia, David, Hoevers, Jacquelien, Honsberger, Nicole, King, Vickie L., Ritter, Dianne, Schwahn, Denise J., Swearingin, Leroy, Weber, Angela, Winkler, M. Teresa C., Millership, Jason

“…Lyme disease, a public health threat of significance to both veterinary and human medicine, is caused by the tick (Ixodes) transmitted spirochete, Borreliella…”
Get full text